The controversy over patenting genes took a new twist in February, when a
patients group got in on the act. PXE International patented methods of treating
the debilitating genetic disease PXE based on the MRP6 gene. Mutations
in MRP6 are to blame for the disease. The group hopes that owning the
gene will allow it to accelerate research, control licence fees and prevent turf
wars between scientists.
To continue reading, today with our introductory offers
Advertisement
More from 51¶¯Âþ
Explore the latest news, articles and features
Popular articles
Trending 51¶¯Âþ articles
1
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
2
Photos reveal unexpected details from the world's first atomic test
3
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
4
How I used psychology to come back from the worst year of my life
5
The distant world that is our best hope of finding alien life
6
The ‘doomsday’ glacier’s giant ice shelf is about to break away
7
Epic dreaming is leaving people exhausted and distressed
8
The 3 things you need to know about protein, according to an expert
9
Putting CO2 into rocks and getting hydrogen out is climate double win
10
Women’s better memories may delay Alzheimer’s diagnosis by years
